Sweden· SE-20050311000019
Tygacil 50 mg Pulver till infusionsvätska, lösning
A medicinal product containing tigecycline, registered in Sweden by Pfizer Europe MA EEIG.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Tigecycline
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20050311000019
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tigecycline in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTIGECYCLINE ACCORDAccord Healthcare S.L.U., Barcelona
- SpainTIGECICLINA ACCORD 50 MG POLVO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
- PolandTigecycline AccordAccord Healthcare S.L.U.
- United KingdomTigecycline 50mg powder for solution for infusion vialsAccord-UK Ltd
- FinlandTigecycline AccordAccord Healthcare S.L.U.
- IrelandTigecycline 50 mg Powder for solution for infusionNoridem Enterprises Limited
- BelgiumTigecyclin Sandoz 50 mgSandoz
- IcelandTigecycline AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Tigecyclin Aptapharma, Tigecyclin Hikma
- Bulgaria · Тигециклин Аптафарма, Тигециклин Ромфарм
- Cyprus · Tigecycline Aptapharma, Tigecycline Sapiens
- Czechia · Tigecycline Aptapharma, Tigecycline Mylan
- Germany · Tigecyclin Amarox, Tigecyclin Carinopharm
- Denmark · Tigecycline Eql Pharma
- Estonia · Tigecycline Inteli, Tigecycline Norameda
- Spain · Tigeciclina Cipla, Tigeciclina Hikma
- Finland · Tigecycline Eql Pharma, Tigecycline Norameda
- France · Tigecycline Amarox, Tigecycline Hikma
- United Kingdom (Northern Ireland) · Tigecycline Aft Pharma Uk, Tigecycline Amarox
- Greece · Digazor, Tigecycline Anfarm
- Croatia · Tigeciklin Aptapharma, Tigeciklin Galenika
- Hungary · Tigeciklin Galenika, Tigeciklin Noridem
- Ireland · Tigecycline Noridem Enterprises
- Iceland · Tigecycline Accord, Tygacil
- Italy · Tigeciclina Amarox, Tigeciclina Cipla
- Liechtenstein · Tigecycline Accord, Tygacil
- Lithuania · Tigecycline Inteli, Tigecycline Norameda
- Latvia · Tigecycline Inteli, Tigecycline Norameda
- Malta · Tigecycline Anfarm, Tigecycline Aptapharma
- Netherlands · Tigecycline Amarox, Tigecycline Hikma
- Norway · Tigecycline Accord, Tigecycline Eql Pharma
- Poland · Tigecycline Aptapharma, Tigecycline Norameda
- Portugal · Tigeciclina Cipla, Tigeciclina Hikma
- Romania · Tigeciclină Aptapharma, Tigeciclina Atb
- Slovenia · Tigeciklin Aptapharma, Tigeciklin Diagonalis
- Slovakia · Tigecycline Aptapharma, Tigecycline Noridem
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f4aee387-6695-43ca-ac94-cb51163e18cf GET /v1/drugs/f4aee387-6695-43ca-ac94-cb51163e18cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20050311000019",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20050311000019",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/tygacil-epar-product-information_sv.pdf"
}See everything about tigecycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.